Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Four methods to analyze H3K27M mutation in diffuse midline gliomas.

Pathology, research and practice - 1 Sept 2020

Zhao Huanying, Fang Xiao, Xue Bing

Abstract excerpt

The histone H3 K27M mutation has been frequently reported in the majority of diffuse midline gliomas, which is considered as a prognostic and predictive biomarker. A number of different methods and platforms including pyrosequencing (PSQ), sanger sequencing, immunohistochemistry (IHC), Mass array and NGS (Next Generation Sequencing) have been used to detect H3K27M mutation in diffuse midline gliomas. However,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Child, Preschool
Share to Glioma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Histones

Share to Immunohistochemistry

Share to Jumonji Domain-Containing Histone Demethylases

Share to Prognosis

Source

Identifiers

PMID: 32825938
DOI: 10.1016/j.prp.2020.153065

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Four methods to analyze H3K27M mutation in diffuse midline gliomas.PMID 32825938Read ↗

Identification of prognostic markers in diffuse midline gliomas H3K27M-mutant.Semantic proximity Read ↗

H3 K27M-mutant diffuse midline gliomas in different anatomical locations.Semantic proximity Read ↗

Epigenetic mechanisms and therapeutic advances in diffuse midline glioma (Review).Semantic proximity Read ↗

Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location.Semantic proximity Read ↗

Characteristics of H3K27M-mutant diffuse gliomas with a non-midline locationSemantic proximity Read ↗

Survival analysis of adult midline-located gliomas and diffuse midline gliomas: beyond the H3K27 mutation paradigm.Semantic proximity Read ↗

Clinico-pathological and molecular characterization of diffuse midline gliomas: is there a prognostic significance?Semantic proximity Read ↗

H3K27-altered diffuse midline gliomas with MAPK pathway alterations: Prognostic and therapeutic implications.Semantic proximity Read ↗

Diffuse Midline Gliomas without the H3 K27M Mutation: Surgical Biopsy is Needed to Better our Diagnostic Understanding.Semantic proximity Read ↗

New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of H3K27M-Mutant Diffuse Midline GliomaSemantic proximity Read ↗

Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adultsSemantic proximity Read ↗

Histone H3K27M Mutation Overrides Histological Grading in Pediatric Gliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.